Date of announcement 2021/03/22

Time of announcement 21:12:26

Date of events 2021/03/22

To which item it meets paragraph 24

Statement

1.Name and nature of the underlying security (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g., dividend yield): Partnership interests in 「CDIB-Kunshan Taiwanese Business Fund」(tentative name)

2.Date of occurrence of the event:2021/03/22

3.No., unit price, and monetary amount of the transaction:

No., unit price: Not applicable, total monetary amount of

the transaction: up to 15% (inclusive) of the final closing

amount of the fund or RMB 150 million, whichever is lower.

4.Counterparty to the trade and its relationship to the company (if the

trading counterparty is a natural person and not a related party of the

company, its name is not required to be disclosed):

Counterpart：A new investment in「CDIB-Kunshan Taiwanese Business Fund」

Its relationship to the Company：After the fund is established,

it will be a related party of

financial statement report.

5.Where the counterparty to the trade is a related party, an announcement

shall also be made of the reason for choosing the related party as trading

counterparty and the identity of the previous owner, including its

relationship with the company and the trading counterparty, the price of the

ownership transfer, and date of transfer:N/A

6.Where the owner of the underlying securities within the past five years

has been a related party of the company, an announcement shall also include

the dates and prices of acquisition and disposal by the related party and

its relationship with the company at the time:N/A

7.Matters related to the creditor’s rights currently being disposed of

(including type of collateral of the disposed creditor’s rights; if the

creditor’s rights are creditor’s rights over a related party, the name of

the related party and the book amount of such creditor’s rights currently

being disposed of must also be announced):N/A

8.Profit (or loss) from the disposal (not applicable in cases of acquisition

of securities) (where originally deferred, the status or recognition shall

be stated and explained):N/A

9.Terms of delivery or payment (including payment period and monetary

amount), restrictive covenants in the contract, and other important

stipulations:Payment will be delivered per the fund-related agreements

10.The manner in which the current transaction was decided, the reference

basis for the decision on price, and the decision-making unit:

The manner in which the current transaction was decided,

the reference basis for the decision

on price：Per fund-related agreements

The decision-making department：

The Board of CVCHK and The Board of CPESH.

11.Net worth per share of company of the underlying securities acquired or

disposed of:Not applicable

12.The discrepancy between the reference price of private placement company

and the transaction amount per share is 20 percent or more:

Not applicable

13.Current cumulative no., amount, and shareholding ratio of the securities

being traded (including the current transaction) as of the date of

occurrence and status of any restriction of rights (e.g.,pledges):

(1) Current cumulative volume: Not applicable

(2) Amount: up to 15% (inclusive) of the final closing amount of

the fund or RMB 150 million, whichever is lower.

(3) Shareholding percentage of holdings of the security being

traded: Up to 15% of the partnership.

(4) Status of any restriction of rights: None.

14.Privately placed securities (including the current transaction) as a

percentage of total assets of the company and shareholder’s equity of the

parent company on the latest financial statements, and the operating capital

on the latest financial statements as of the date of occurrence:

(1) to the total assets: 6.27%、1.94%。

(2) to the shareholder's equity: 6.67%、2.06%.

(3) The operating capital: NTD 10,255,404 thousand.

15.Broker and broker's fee:Not applicable

16.Concrete purpose or use of the acquisition or disposition:

For the needs of investment portfolio expansion

17.Whether the directors expressed any objection to the present transaction:

None

18.Whether the trading counterparty is a related party:Yes

19.Date of approval by board of directors:2021/03/22

20.Recognition date by supervisors or approval date by audit committee:

Not applicable, because the transaction applies to

Article 45 of the Financial Holding Company Act

21.Whether the CPA issued an opinion on the unreasonableness of the current

transaction:Not applicable.

22.Name of the CPA firm:Not applicable.

23.Name of the CPA:Not applicable.

24.License no.of the CPA:Not applicable.

25.Any other matters that need to be specified:

(1)CPESH, a 100%-owned subsidiary of CDIB Capital Group,

will set up a joint venture company

(The name not yet decided, and the tentative capital

is RMB 10 million) with a 65% shareholding to

raise and set up CDIB-Kunshan Taiwanese Business Fund.

The new joint venture company will serve as the general

partner of CDIB-Kunshan Taiwanese Business Fund.

(2) The amount size of CDIB-Kunshan Taiwanese Business Fund

is tentatively set at RMB 1 billion.

The total investment amount of CVCHK, CPESH is temporarily serves as

the general partner of the fund or CPESH indirectly invested through

the new joint venture company, will be

up to 15% (inclusive) of the final closing amount of the fund or

RMB 150 million, whichever is lower.

(3) These transactions will not be processed until approved by the competent authority.

(4)The full name ofCVCHK is CDIB Venture Capital (Hong Kong)Corporation Limited；and the full name of CPESH is CDIB Private Equity (China) Corporation.